ClinConnect ClinConnect Logo
Search / Trial NCT02941653

Potassium Oxalate and Potassium Nitrate and Post-bleaching Sensitivity

Launched by UNIVERSIDADE FEDERAL DE SERGIPE · Oct 20, 2016

Trial Information

Current as of June 04, 2025

Completed

Keywords

ClinConnect Summary

Methods \& Materials:

This clinical trial was approved by the Scientific Review Committee and by the Committee for the Protection of Human Subjects of the local university (CAAE 60259316.2.0000.5546).

Trial design:

This study will be a randomized, triple-blinded, placebo-controlled clinical trial, and split mouth study design.

The patients included will be submitted to two in-office bleaching sessions receiving the potassium nitrate 2% and postassium oxalate 5% desensitivity gel application on vestibular surface, for 10 minutes. A delay of 1 week between the sessions will be established...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients included in this clinical trial will be at least 18 years old with good oral health;
  • Patients presenting all six upper anterior teeth with shade mismatching with 2.5 M2 (Vita Bleachguide 3D-Master scale, Vita-Zahnfabrik, Bad Sackingen, Germany) or darker will be included.
  • Exclusion Criteria:
  • Patients with any of the six upper anterior teeth with caries;
  • Restorations in anterior teeth'
  • Patients with tooth severe discoloration (e.g., stains caused by tetracycline);
  • Presence of enamel hypoplasia;
  • Presence of gingival recession or dentin exposure;
  • Presence of tooth pulpitis or endodontics;
  • Participants submitted to previous bleaching procedures;
  • Patients with prior tooth sensitivity;
  • Patients with known allergy to any component of medication used in the study;
  • Pregnant or breastfeeding will also be also excluded.

About Universidade Federal De Sergipe

The Universidade Federal de Sergipe (UFS) is a prominent public educational institution in Brazil, dedicated to advancing research and innovation in the health sciences. As a clinical trial sponsor, UFS is committed to conducting high-quality research that adheres to ethical standards and regulatory requirements. The university's diverse team of researchers and healthcare professionals collaborates to explore new treatments and interventions, aiming to improve patient outcomes and contribute valuable knowledge to the scientific community. UFS emphasizes a multidisciplinary approach, fostering partnerships with national and international institutions to enhance the impact and reach of its clinical studies.

Locations

Aracaju, Sergipe, Brazil

Patients applied

0 patients applied

Trial Officials

Flavia Pardo S Nahsan, PhD

Principal Investigator

Universidade Federal de Sergipe

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials